| Literature DB >> 36034653 |
Sahar Foorginezhad1, Gangqiang Yu2, Xiaoyan Ji1.
Abstract
CO2 capture is essential for both mitigating CO2 emissions and purifying/conditioning gases for fuel and chemical production. To further improve the process performance with low environmental impacts, different strategies have been proposed, where developing liquid green absorbent for capturing CO2 is one of the effective options. Ionic liquids (IL)/deep eutectic solvents (DES) have recently emerged as green absorbents with unique properties, especially DESs also benefit from facile synthesis, low toxicity, and high biodegradability. To promote their development, this work summarized the recent research progress on ILs/DESs developed for CO2 capture from the aspects of those physical- and chemical-based, and COSMO-RS was combined to predict the properties that are unavailable from published articles in order to evaluate their performance based on the key properties for different IL/DES-based technologies. Finally, top 10 ILs/DESs were listed based on the corresponding criteria. The shared information will provide insight into screening and further developing IL/DES-based technologies for CO2 capture.Entities:
Keywords: CO2 capture; COSMO-RS; deep eutectic solvents; green absorbents; ionic liquid
Year: 2022 PMID: 36034653 PMCID: PMC9399623 DOI: 10.3389/fchem.2022.951951
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.545
Physical-based ILs reported in 2021–2022.
| Abbreviation | Full name |
|
| Viscosity (cP) | Selectivity | Absorption capacity (mol/kg) | References | |
|---|---|---|---|---|---|---|---|---|
| Initial | Final | |||||||
| [HMIM][TCB] | 1-hexyl-3-methylimidazolium tetracyanoborate | 293 | 28 | — | — | — | 0.992 |
|
| [BMIM][Br] | 1-butyl-3-methylimidazolium bromide | 303.15 | 1 | — | — | 2.417 (H2S/CO2) | 0.114 |
|
| P [VBIm][SCN] | Poly (1-butyl-3-vinylimidazolium thiocyanate) | 298.15 | 1 | — | — | — | 0.525 |
|
| P [VBIm][BF4] | Poly (1-butyl-3-vinylimidazolium tetrafuoroborate) | — | — | — | 0.216 | |||
| P [VBIm][Br] | Poly (1-butyl-3-vinylimidazolium bromide) | — | — | — | 0.136 | |||
| [EMIM][FAP] | 1-ethyl-3-methylimidazo tris (pentafluoroethyl) trifluorophosphate | 293.15 | 50 | 75 at 293 | — | — | ∼4.195 |
|
| [BMIM][FAP] | 1-butyl-3-methylimidazo tris (pentafluoroethyl) trifluorophosphate | 93 at 293 | — | — | ∼4.628 | |||
| [HMIM][FAP] | 1-hexyl-3-methylimidazo tris (pentafluoroethyl) trifluorophosphate | 116 at 293 | — | — | ∼5.791 | |||
| [(2,2)OEtIm][Tf2N]2 | 1,1′,3,3′-bis(3,6-dioxaoctane-1,8-diyl) bis(imidazolium) bis (trifluoromethanesulfonyl) imide | 298.15 | 10 | — | — | — | 0.368 |
|
| [(3,3)OEtIm][Tf2N]2 | 1,1′,3,3′-bis(3,6,9-trioxaundecane-1,11-diyl)bis(imidazolium) bis (trifluoromethanesulfonyl) imide | — | — | — | 0.433 | |||
| [(3,3)OEtDABCO][Tf2N]4 | 1,1′,4,4′-bis(3,6,9-trioxaundecane-1,11-diyl)bis (1,4-diazoniabicyclo [2.2.2]octane) bis(trifluoromethanesulfonyl) imide | — | — | — | 0.261 | |||
| [(3,3)OEtDABCO][BETI]4 | 1,1′,4,4′-bis(3,6,9-trioxaundecane-1,11-diyl)bis(1,4-diazoniabicyclo [2.2.2]octane) bis(pentafluoroethanesulfonyl) imide | — | — | — | 0.193 | |||
| [bis(octamethylene)-bis(imidazolium)][Tf2N]2 | 1,1′,3,3′-bis(octamethylene)bis (imidazolium) bis(trifluoromethanesulfonyl) imide | — | — | — | 0.382 | |||
| [bis(decamethylene)-bis(imidazolium)][Tf2N]2 | 1,1′,3,3′-bis(decamethylene)bis (imidazolium) bis(trifluoromethanesulfonyl) imide | — | — | — | 0.302 | |||
| [N2222][PF6] | Tetraethylammonium hexafluorophosphate | 303.15 | 40 | — | — | 1.57 (CO2/CH4) | 1.486 |
|
| [N4444][PF6] | Tetrabutylammonium hexafluorophosphate | — | — | 1.24 (CO2/CH4) | 1.277 | |||
| [C12MIM][PF6] | 1-dodecyl-3-methylimidazolium hexafluorophosphate | — | — | 5.53 (CO2/CH4) | 3.643 | |||
| [C16MIM][PF6] | 1-hexadecyl-3-methylimidazolium hexafluorophosphate | — | — | 4.21 (CO2/CH4) | 2.08 | |||
| [BZMIM][Tf2N] | 1-benzyl-3-methylimidazolium bis(trifluoromethylsulfonyl) imide | 303.15 | 30.496 | — | — | 2.89 (CO2/H2S) | 4.23 |
|
| [EMIM][Tf2N] | 1-ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide | 298.15 | 40 | — | — | — | ∼2.746 |
|
| [BMIM][Tf2N] | 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl) imide | 35 | — | — | — | ∼2.201 | ||
| [HMIM][Tf2N] | 1-hexyl-3-methylimidazolium bis(trifluoromethylsulfonyl) amide | 40 | — | — | — | ∼2.421 | ||
| [OMIM][Tf2N] | 1-octyl-3-methylimidazolium bis(trifluoro-methylsulfonyl) imide | 40 | — | — | — | 2.499 | ||
| [EMIM][CH3SO3] | 1-ethyl-3-methylimidazolium methanesulfonate | 293.15 | 45 | — | — | — | 3.2368 |
|
| [APMIm][Tf2N] | 1-aminopropyl-3-imidazolium bis (trifluoromethylsulfonyl) imine | 303.15 | 1 | — | — | — | 0.706 |
|
| [BVIM][Tf2N] | 1- butyl-3-vinylimidazolium bis(trifluoromethylsulfonyl)imide | 303.2 | 71.1 | 77 at 298.15 K | — | — | 6.268 |
|
| [N4222][Tf2N] | Butyltriethylammonium bis(trifluoromethylsulfonyl) imide | 303.2 | 124.2 | 99 at 298.15 K | — | — | 4.180 | |
| [P4441][Tf2N] | Tributylmethylphosphonium bis(trifluoromethylsulfonyl) imide | 303.2 | 103.9 | 209 at 298.15 K | — | — | 6.063 | |
Chemical-based ILs reported in 2021–2022.
| Abbreviation | Full name |
|
| Viscosity (cP) | Selectivity | Absorption capacity (mol/kg) | References | ||
|---|---|---|---|---|---|---|---|---|---|
| Initial | Final | ||||||||
| [EHA][C5] | 2-ethylhexylammonium pentanoate | 298.15 | 30 | 680.4233 at 293.15 | — | — | ∼2.68 |
| |
| [EHA][C6] | 2-ethylhexylammonium hexanoate | 423.353 at 293.15 | — | — | ∼2.852 | ||||
| [EHA][C7] | 2-ethylhexylammonium heptanoate | 288.4767 at 293.15 | — | — | ∼3.007 | ||||
| [BEHA][C5] | Bis-(2-ethylhexyl) ammonium pentanoate | 36.8410 at 293.15 | — | — | ∼1.834 | ||||
| [BEHA][C6] | Bis-(2-ethylhexyl) ammonium hexanoate | 33.7660 at 293.15 | — | — | ∼1.901 | ||||
| [BEHA][C7] | Bis-(2-ethylhexyl) ammonium heptanoate | 37.6123 at 293.15 | — | — | ∼2.126 | ||||
| [EMIM][Gly] | 1-ethyl-3- methylimidazolium glycinate | 298.15 | — | — | — | — | 8.645 |
| |
| [DMEDAH] [Py] | N,N-dimethylethylenediamine pyrazole | 295.15 | 1.01 | — | — | — | 5.25 |
| |
| [DMEDAH] [Im] | N,N-dimethylethylenediamine imidazole | — | — | — | 4.91 | ||||
| [DMEDAH] [Tz] | N,N-dimethylethylenediamine 1,2,4-triazole | — | — | — | 4.32 | ||||
| [K (AMP)2][Im] | K+ chelated 2-amino-2-methyl-1-propanol imidazole | 333.2 | 1 | 138.7 at 332.2 K | — | — | 4.183 |
| |
| [K (AMB)2][Im] | K+ chelated 2-amino-1-butanol imidazole | 53.34 at 332.2 K | — | — | 3.832 | ||||
| [K (DLAMP)2][Im] | K+ chelated dl-1-amino-2-propano imidazole | 50.90 at 332.2 K | — | — | 3.9 | ||||
| [K (MEA)2][Im] | K+ chelated monoethanol amine imidazole | 43.03 at 332.2 K | — | — | 3.328 | ||||
| [P66614][Benzim] | Trihexyltetradecyl- phosphonium benzimidazolide | 295.15 | 1 | 1,087 at 298.15 | — | — | 1.21 |
| |
| [P2224][4-Triaz] | Triethyl-butyl-phosphonium, 1,2,4, triazolide | 353.15 | 3.080 | — | — | — | 1.85 |
| |
| [P66614][2-CNpyr] | Trihexyl-tetradecyl-phosphonium 2-cyanopyrrolide | 313.15 | 0.937 | — | — | — | 1.207 | ||
| [P66614][SCH3BnIm] | Trihexyl-tetradecyl-phosphonium 2-methylthio-benzimidazolide | 333.15 | 3.164 | — | — | — | 0.972 | ||
| [P66614][4-Triaz] | Trihexyl-tetradecyl-phosphonium, 1,2,4, triazolide | 313.15 | 0.753 | — | — | — | 1.05 | ||
| [P66614][Inda] | Trihexyl-tetradecyl-phosphonium indazolide | 313.15 | 3.216 | — | — | — | 1.561 | ||
| [P66614][BrBnIm] | Trihexyl-tetradecyl-phosphonium 6-bromo-benzimidazolide | 313.15 | 2.693 | — | — | — | 1.41 | ||
| [P66614][CF3pyra] | Trihexyl-tetradecyl-phosphonium 3-trifluoromethyl-pyrazolide | 313.15 | 4.092 | — | — | — | 1.661 | ||
| [P66614][BnIm] | Trihexyl-tetradecyl-phosphonium benzimidazolide | 313.15 | 3.098 | — | — | — | 1.597 | ||
| [MOBMIM][Lys] | 1-methoxylbutyl-3-methylimidazolium lysine | 323.15 | 5 | 3,201.13 | — | — | 6.721 |
| |
| [MOBMIM][His] | 1-methoxylbutyl-3-methylimidazolium histidine | 2,986.94 | — | — | 7.026 | ||||
| [MOBMIM][Arg] | 1-methoxylbutyl-3-methylimidazolium arginine | 5,631.12 | — | — | 6.086 | ||||
| [MOBMIM][Gly] | 1-methoxylbutyl-3-methylimidazolium glycine | 536.31 | — | — | 9.66 | ||||
| [DBNH][Im] | 1,5-diazabicyclo [4,3,0]non-5-ene/imidazole | 313.2 | 1 | 8.3 | — | — | 3.38 |
| |
| [DBUH][Im] | 1,8-diazabicyclo [5,4,0]undec-7-ene/imidazole | 18.3 | — | — | 3.086 | ||||
| [DBNH][Pyr] | 1,5-diazabicyclo [4,3,0]non-5-ene/Pyrazole | 5.1 | — | — | 3.381 | ||||
| [DBUH][Pyr] | 1,8-diazabicyclo [5,4,0]undec-7-ene/Pyrazole | 9.7 | — | — | 3.041 | ||||
| [EMIM][OAc] | 1-ethyl-3-methylimidazolium acetate | 298.15 | 1.836 | — | — | — | 2.16 |
| |
| [Cu(OctNH2)4][Tf2N]2 | — | 298 | 1 | — | — | — | 0.061 |
| |
| [Zn(OctNH2)4][Tf2N]2 | — | — | — | — | 0.192 | ||||
| [Co(OctNH2)4][Tf2N]2 | — | — | — | — | 0.307 | ||||
| [Ni(OctNH2)4][Tf2N]2 | — | — | — | — | 0.395 | ||||
| [Mg(OctNH2)4][Tf2N]2 | — | — | — | — | 0.455 | ||||
| [Li(OctNH2)4][Tf2N]2 | — | — | — | — | 0.654 | ||||
| [Ni(DecNH2)4][Tf2N]2 | — | — | — | — | — | 0.377 | |||
| [Mg (DecNH2)4][Tf2N]2 | — | — | — | — | 0.455 | ||||
| [CuZn(DecNH2)4][Tf2N]2 | — | — | — | — | 0.0238 | ||||
| [CuMg(DecNH2)4][Tf2N]2 | — | — | — | — | 0.068 | ||||
| [CuZnNiMg(DecNH2)4][Tf2N]2 | — | — | — | — | 0.0384 | ||||
| [B4MPyr][L-Arg] | 1-butyl-4-methyl pyridinium | Arginate | 298.15 | 2 | — | — | — | 1.45 |
|
| [B4MPyr][L-Lys] | 1-butyl-4-methyl pyridinium | Lysinate | — | — | —- | 1.24 | |||
| [B4MPyr][L-His] | Hisdinate | — | — | —- | 1.11 | ||||
| [B4MPyr][L-Tyr] | Tyrosinate | — | — | —- | 0.966 | ||||
| [B4MPyr][Gly] | Glycinate | — | — | —- | 1.46 | ||||
| [B4MPyr][L-Ala] | Alaninate | — | — | —- | 1.42 | ||||
| [B4MPyr][L-Val] | Valinate | — | — | —- | 1.08 | ||||
| [B4MPyr][L-Pro] | Prolinate | — | — | —- | 1.06 | ||||
| [Cho][Gly] | Cholinium glycinate | 298.15 | 4 | — | — | — | 6.20 |
| |
| [Cho][Ala] | Cholinium alaninate | — | — | — | 4.222 | ||||
| [Cho][Val] | Cholinium valinate | — | — | — | 1.093 | ||||
| [P4444][OAc] | Tetra butyl phosphonium acetate | 343.2 | 14.01 | — | — | — | ∼1.91 |
| |
| [P2228][3ClInda] | Triethyl (octyl) phosphonium 3-chloroindazole | 332.1 | 0.763 | 852 at 298.2 | — | — | 2.188 |
| |
| [P2228][4Br3MePyra] | Triethyl (octyl) phosphonium 4-bromo-3-methyl-1H-pyrazole | 321.8 | 0.798 | 280 at 298.2 | — | — | 2.298 | ||
| [P2228][4BrInda] | Triethyl (octyl) phosphonium 4-bromoindazole | 332 | 0.639 | 1,030 at 298.1 | — | — | 2.124 | ||
| [P2228][6BrInda] | Triethyl (octyl) phosphonium 6-bromoindazole | 332 | 0.833 | 982 at 298.1 | — | — | 2.334 | ||
| [P2228][4BrIm] | Triethyl (octyl) phosphonium 4-bromoimidazole | 332.1 | 0.772 | 588 at 298.2 | — | — | 1.665 | ||
| [P2228][6CNInda] | Triethyl (octyl) phosphonium 6-cyanoindazole | 337.3 | 0.479 | 956 at 298.2 | — | — | 1.629 | ||
| [P2228][3IPyra] | Triethyl (octyl) phosphonium 3-iodopyrazole | 332.2 | 0.651 | 224 at 298.2 | — | — | 1.951 | ||
| [tetraEG (MIM)2][Br]2 | 3,30 -(tetraethyleneglycol-1,11-diyl)bis(1-methyl-1h-imidazolium) bromide | 343.139 | 4.9916 | 39,631 at 333.149 K | — | — | 0.233 |
| |
| [tetraEG (MIM)2] [OAc]2 | 3,30 -(tetraethyleneglycol-1,11-diyl) bis(1-methyl-1h-imidazolium) acetate | 343.051 | 4.9829 | 2,251.9 at 323.151 K | — | — | 1.735 | ||
| [C4MIM]2 [Mal] | 1-butyl-3-methylimidazolium malonate | 343.106 | 4.9971 | 75,670 at 313.15 K | — | — | 1.83 | ||
| [C4MIM]2 [Glut] | 3-butyl-1-methylimidazolium glutarate | 343.106 | 4.9971 | 19,082 at 303.148 K | — | — | 1.834 | ||
| [DBUH][MLU] | 1,8-diazabicyclo [5.4.0] undec-7-ene methyl urea | 313 | 1 | ∼520 at 293.15 K | — | — | 1.75 |
| |
| [DBUH]2 [DMU] | 1,8-diazabicyclo [5.4.0] undec-7-ene 1,3-dimethylurea | 313 | 1 | ∼45 at 293.15 | — | — | 2.68 |
| |
Physical-based DESs reported in 2021–2022.
| Abbreviation | Structure |
|
| Viscosity (cP) | Selectivity | Absorption capacity (mol/kg) | References | |||
|---|---|---|---|---|---|---|---|---|---|---|
| HBA | Molar ratio (HBA:HBD) | HBD | Initial | Final | ||||||
| [EAHC][TEPA] | Ethanol amine hydrochloride | 1:9 | Tetraethylenepenta amine | 303.15 | 16.03 | — | — | — | 9.671 |
|
| [ChCl][TEG] | Choline chloride | 1:3 | Triethyleneglycol | 303.15 | 26.196 | — | — | — | 0.992 |
|
| [GI][AT] | Guanidine isothiocyanate | 1:4 | Acetamide | 303.15 | 5.768 | 16.53 ± 0.15 at 303.15 K | — | 97 (NH3/CO2) | 0.214 ± 0.004 |
|
| [3Im][PTSA] | Imidazole | 3:1 | P-toluenesulfonic acid | 303.15 | 14.475 | ∼55 at 302.5 K | — | — | 1.0059 |
|
| [3.5Im][PTSA] | 3.5:1 | 14.982 | ∼44 at 302.5 K | — | — | 1.0642 | ||||
| [4Im][PTSA] | 4:1 | 14.821 | ∼42 at 302.5 | — | — | 1.0959 | ||||
| [MTPPhBr][4 EG] | Methyltriphenylphosphonium Bromide | 1:4 | Ethylene glycol | 303.15 | 10.19 | — | — | — | 0.438 |
|
| [MTPPhBr][4DEG] | 1:4 | Diethylene glycol | 9.21 | — | — | — | 0.390 | |||
| [MTPPhBr][3GLY] | 1:3 | Glycerol | 10.39 | — | — | — | 0.373 | |||
| [TBABr][OA] | Tetrabutylammonium bromide | 1:2 | Octanoic acid | 313.15 | 40 | — | — | — | 2.15 |
|
| [TBABr][DA] | Tetrabutylammonium bromide | 1:2 | Decanoic acid | — | — | — | 2.53 | |||
| [DL-menthol][DA] | DL-menthol | 2:1 | Dodecanoic acid | — | — | — | 2.06 | |||
| [TBAB][DEC] | Tetrabutylammonium bromide | 1:2 | Decanoic acid | 303.15 | 11.17 | — | — | — | 0.679 |
|
| [TBAB][HEX] | Tetrabutylammonium bromide | 1:4 | Hexanoic acid | 303.15 | 13.35 | — | — | — | 0.954 | |
| [TEAC][HEX] | Tetraethylammonium chloride | 1:4 | Hexanoic acid | 303.15 | 12.63 | — | — | — | 0.837 | |
| [ChCl][MDEA] | Choline chloride | 1:7 | N-methyldiethanolamine | — | — | ∼75 at 303.15 K | — | — | 1.389 |
|
| [ChCl][LvAc] | Choline chloride | 1:3 | Levulinic-acid | 298.15 | 6 | — | — | — | ∼1.5 |
|
| [ChCl][EG] | Choline chloride | 1:2 | Ethylene glycol | 298.15 | 60 | 36 at 298.15 K | — | — | 1.363 |
|
| [ChCl][U] | Choline chloride | 1:2 | Urea | 735.5 at 298.15 K | — | — | 0.455 | |||
| [ChCl][MEA] | Choline chloride | 1:5 | Monoethanolamine | 313.15 | 12.5 | 20 at 313.15 K | — | 20 (CO2/CH4) at 313.15 K and 12.5 bar | ∼3.775 |
|
Chemical-based DESs reported in 2021–2022.
| Abbreviation | Structure |
|
| Viscosity (cP) | Selectivity | Absorption capacity (mol/kg) | References | |||
|---|---|---|---|---|---|---|---|---|---|---|
| HBA | Molar ratio (HBA:HBD) | HBD | Initial | Final | ||||||
| [ChCl][MEA] | Choline chloride | 1:5 | Monoethanolamine | — | — | ∼25 at 303.15 K | — | — | 6.17 |
|
| [ChCl][DEA] | 1:6 | Diethanolamine | — | — | ∼340 at 303.15 K | — | — | 3.893 | ||
| [MEAHCl][MDEA] | Monoethanolamine hydrochloride | 1:3 | Methyldiethanolamine | 298.15 | 1 | ∼270 | 1,500 | — | 2.631 |
|
| [DEAHCl][MDEA] | Diethanolamine hydrochloride | Methyldiethanolamine | ∼270 | ∼1,460 | — | ∼2.459 | ||||
| [MDEAHCl][MDEA] | N-methyl diethanolamine hydrochloride | Methyldiethanolamine | ∼200 | ∼410 | — | ∼1.35 | ||||
| [DBU][Py] | 1,8-Diazabicyclo [5.4.0] undec-7-ene | 1:1 | Pyrrolidine | 303 | 1 | — | — | 6.5 |
| |
| [DBU][Pyr] | 2:1 | 2-Pyrrolidinone | 19.1 | — | — | 8.193 | ||||
| [DBU][Oxa] | Oxazolidinone | — | — | 6.336 | ||||||
| [DBU][ | Ethyleneurea | 50.1 | — | — | 7.504 | |||||
| [TBAC][AP] | Tetrabutylammonium chloride | 1:4 | 3-amino-1-propanol | 1.6 | 77.36 at 298.15 K | — | — | ∼4.582 |
| |
| [TBAB][AP] | Tetrabutylammonium bromide | 1 | 84.69 at 298.15 K | — | — | ∼3.854 | ||||
| [TEAC][AP] | Tetraethylammonium chloride | 0.6 | 42.37 at 298.15 K | — | — | ∼4.076 | ||||
| [Gly][MEA] | Glycine | 1:4 | Monoethanolamine | 298.15 | 1.01 | — | — | — | ∼5.227 |
|
| [Pro][MEA] | Proline | Monoethanolamine | — | — | — | ∼4.590 | ||||
| [Pro][MDEA] | Proline | Monoethanolamine | — | — | — | ∼1.056 | ||||
| [Gly]: [MEA]/EG | Glycine:monoethanolamine | 1:4/30 wt% | Ethylene glycol | 303.15 | 1.01 | — | — | — | ∼5 |
|
| [Pro]: [MEA]/EG | Proline: monoethanolamine | 1:4/30 wt% | Ethylene glycol | 303.15 | 1.01 | — | — | — | ∼4.09 |
|
| [Et4N][Thy]:EG | Tetraethylammonium thymol | 1:2 | Ethylene glycol | 298.18 | 1 | 292 | — | — | 5.23 |
|
| [Et4N][Car]:EG | Tetraethylammonium carvacrol | 1:2 | Ethylene glycol | 298.15 | 1 | 279 | — | — | 5.06 |
|
| [Et4N][Thy]:4CH3-Im | Tetraethylammonium thymol | 1:2 | 4-methylimidazole | 298.15 | 1 | 1,298 | — | — | 4.86 |
|
| [Et4N][Car]:4CH3-Im | Tetraethylammonium carvacrol | 1:2 | 4-methylimidazole | 298.15 | 1 | 891 | — | — | 4.75 |
|
| [DBUH][MLU]:EG | 1,8-diazabicyclo [5.4.0]undec-7-ene methyl urea | 1:1 | Ethylene glycol | 313.15 | 1 | ∼400 | — | — | 3.14 |
|
| [DBUH][MLU]:EG | 1,8-diazabicyclo [5.4.0]undec-7-ene methyl urea | 1:2 | Ethylene glycol | 313.15 | 1 | ∼220 at 293.15 K | — | — | 2.70 |
|
| [DBUH][MLU]:EG | 1,8-diazabicyclo [5.4.0]undec-7-ene methyl urea | 1:4 | Ethylene glycol | 313.15 | 1 | — | — | — | 2 |
|
| [DBUH]2 [DMU]:EG | 1,8-diazabicyclo [5.4.0]undec-7-ene 1,3-dimethylurea | 1:1 | Ethylene glycol | 313.15 | 1 | — | — | — | 2.95 |
|
| [DBUH]2 [DMU]:EG | 1,8-diazabicyclo [5.4.0]undec-7-ene 1,3-dimethylurea | 1:2 | Ethylene glycol | 313.15 | 1 | ∼190 at 293.15 K | - | — | 3.70 |
|
| [DBUH]2 [DMU]:EG | 1,8-diazabicyclo [5.4.0]undec-7-ene 1,3-dimethylurea | 1:4 | Ethylene glycol | 313.15 | 1 | ∼110 at 293.15 K | — | — | 3.05 |
|
| [EMIM][2CNpyr]:EG | 1-ethyl-3-methylimidazolium 2- cyanopyrrolide | 1:1 | Ethylene glycol | 298.15 | 1 | — | — | — | ∼3.5 |
|
| [EMIM][2CNpyr]:EG | 1-ethyl-3-methylimidazolium 2- cyanopyrrolide | 1:2 | Ethylene glycol | 298.15 | 1 | 45.1 ± 0.2 at 298.15 K | 88.2 ± 1.5 at 298.15 K | — | 2.59 |
|
| [DBUH][Car]:EG | 1,8-diazabicyclo- [5,4,0]undec-7-ene carvacrol | 1:4 | Ethylene glycol | 298.15 | 1 | 166 at 298.15 K | — | — | 8.99 |
|
| [DBUH][Car]:EG | 1,8-diazabicyclo- [5,4,0]undec-7-ene carvacrol | 1:3 | Ethylene glycol | 298.15 | 1 | 228 at 298.15 K | — | — | 8.10 |
|
| [DBUH][Car]:EG | 1,8-diazabicyclo- [5,4,0]undec-7-ene carvacrol | 1:2 | Ethylene glycol | 298.15 | 1 | 389 at 298.15 K | — | — | 6.82 |
|
| [DBUH][Thy]:EG | 1,8-diazabicyclo- [5,4,0]undec-7-ene thymol | 1:4 | Ethylene glycol | 298.15 | 1 | 179 at 298.15 K | — | — | 9.08 |
|
| [DBUH][Thy]:EG | 1,8-diazabicyclo- [5,4,0]undec-7-ene thymol | 1:3 | Ethylene glycol | 298.15 | 1 | 263 at 298.15 K | — | — | 8.10 |
|
| [DBUH][Thy]:EG | 1,8-diazabicyclo- [5,4,0]undec-7-ene thymol | 1:2 | Ethylene glycol | 298.15 | 1 | 477 at 298.15 K | — | — | 6.82 |
|
10 physical- and chemical-based ILs and DESs with high CO2 absorption capacity.
| ILs | |||
|---|---|---|---|
| Physical-based | Absorption capacity (mol/kg) | Chemical-based | Absorption capacity (mol/kg) |
| [BVIM][Tf2N] | 6.268 | [DETAH][Im] | 11.91 |
| [P4441][Tf2N] | 6.063 | [DETAH][Py] | 11.39 |
| [HMIM][FAP] | ∼5.791 | [DETAH][Gly] | 10.15 |
| [BMIM][FAP] | ∼4.628 | [DETAH][Tz] | 10.10 |
| [BZMIM][Tf2N] | 4.23 | [TETAH][Lys] | 9.72 |
| [BMIM][BF4] | 4.2 | [MOBMIM][Gly] | 9.66 |
| [EMIM][FAP] | ∼4.195 | [EMIM][Gly] | 8.645 |
| [N4222][Tf2N] | 4.180 | [DETAH][Lys] | 7.68 |
| [AMIM][Tf2N] | 3.88 | [BMIM][Gly] | 7.251 |
| [DEA][Bu] | 3.71 | [MOBMIM][His] | 7.026 |
|
| |||
| [EAHC][TEPA] (1:9) | 9.671 | [TBD][EG] (1:4) | 12.9 |
| [TPPB][DEG] (1:4) | 7.29 | [DBU][EG] (1:4) | 12.48 |
| [ATPPB][TEG] (1:4) | 6.42 | [ChCl][U]/AMP (1:2) | 11 |
| [TPPB][DEG] (1:10) | 5.79 | [ChCl][TEG]/AMP (1:4) | 10.51 |
| [TPPB][DEG] (1:16) | 5.24 | [ChCl][DEG]/AMP (1:4) | 10.36 |
| [L-Arg][GLY] (1:6) | 4.92 | [ChCl][U]/MAE (1:2) | 9.97 |
| [ATPPB][TEG] (1:10) | 4.77 | [ChCl][U]/MEA (1:2) | 9.84 |
| [ChCl][La] (1:1) | 4.52 | [DBUH][Thy]/EG (1:4) | 9.08 |
| [Al][La] (1:1) | 4.30 | [DBUH][Car]/EG (1:4) | 8.99 |
| [ATPPB][TEG] (1:16) | 4.29 | [DBN][BMIMCl][Im] (1:1:2) | 8.92 |
FIGURE 1Excess enthalpies of equimolar CO2 in physical-based ILs (A), chemical-based ILs (B), physical-based DESs (C) and chemical-based DESs (D) predicted by the COSMO-RS model at 298.15 (K)
FIGURE 3Viscosity of chemical- and physical-based ILs predicted by COSMO-RS.
FIGURE 2Selectivities of CO2/CO, CO2/H2, CO2/CH4, and CO2/N2 in physical-based ILs (A), chemical-based ILs (B), physical-based DESs (C) and chemical-based DESs (D) predicted by the COSMO-RS model at 298.15 (K)
FIGURE 4Top 20 physical-based ILs based on their properties.
FIGURE 7Top 20 chemical-based DESs based on their properties.
Suggested top 10 ILs/DESs.
| ILs | DESs | ||
|---|---|---|---|
| Physical-based |
|
|
|
|
| [DETAH][Im] | [EAHC][TEPA] (1:9) | TBD-EG (1:4) |
|
| [DETAH][Py] | [TPPB][DEG] (1:4) | DBU-EG (1:4) |
|
| [DETAH][Gly] | [ATPPB][TEG] (1:4) | [DBUH][Thy]/EG (1:4) |
|
| [DETAH][Tz] | [TPPB][DEG] (1:10) | [DBUH][Thy]/EG (1:3) |
|
| [MOBMIM][Gly] | [TPPB][DEG] (1:16) | [DBUH][Car]/EG (1:4) |
|
| [BMIM][Gly] | [L-Arg][GLY] (1:6) | [ChCl][EA][Pz] (1:7:1) |
|
| [MOBMIM][His] | [ATPPB][TEG] (1:10) | [DBUH][Car]/EG (1:3) |
|
| [DMEDAH][Py] | [ChCl][La] (1:1) | [DBUH][BA] (1:4) |
|
| [DMEDAH][Im] | [Be][La] (1:1) | [TBD][BA] (1:4) |
|
| [P4442][Cy-Suc] | [ChCl][Fr] (1:1) | [MEACl][AP] (1:4) |